Rezolute, Inc. — Director's Dealing 2017

Jan 17, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2016-10-31

Reporting Person: Welch David F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-10	Common Stock	P	5000	$0.9141	Acquired	5000	Direct
2017-01-11	Common Stock	P	5000	$0.9385	Acquired	10000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-31	Stock Option (right to buy)	$1.20	A	750000	Acquired	2026-10-31	Common Stock (750000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1766432	Indirect

Footnotes

F1: The Reporting Person is President of LRFA, LLC and has voting and dispositive power of the shares of the Issuer's common stock owned by LRFA, LLC.

F2: The option vests in forty-eight equal installments beginning on the date so indicated and every month thereafter, such grant vested in full at 4 years.